Medtronic plc Stock News

Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.

Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.

Dividend stocks are an excellent source of passive income. Some dividend payers are markedly safer investments than their peers, however.

Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Stre

Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago.

Medtronic reported adjusted per-share earnings of $1.30, beating Wall Street's call for $1.26, according to FactSet.

Medtronic's revenue soars 88%, leading healthcare innovation, while Non-GAAP EPS up 40%, showcasing steady growth. Medtronic has decent growth opportunities and limited risks. With Medtronic's P/E rat

Not every stock has been swept up in the stock market's euphoria. Shares of Medtronic and Sanofi have been more muted lately.

Medtronic has a history of dividend increases and is well-positioned for long-term growth in the healthcare industry. The company's financial performance has been solid, with stable margins and consis

In the latest trading session, Medtronic (MDT) closed at $83.68, marking a +0.11% move from the previous day.

In the bustling realm of forward-looking investments, robotics stocks stand out for their tremendous potential and relevance. These dynamic assets offer around-the-clock productivity, virtually uninte

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Medtronic (MDT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the q

Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal third-quarter performance.

Investors are back to looking at value stocks as many see high-flying growth as a bubble poised to burst. Even index investors focused on benchmarks like the S&P 500 are increasingly wary of the risks